Merck Announces Elevian as Winner of its North American Advance Biotech Grant
Recombinant protein has the potential to accelerate ischemic and hemorrhagic stroke recovery
24-Jan-2022 -
Merck announced that Elevian has been selected as the North American winner of its 2021 Advance Biotech Grant Program. The early-stage biotechnology company, which is based in Allston, Massachusetts, USA, was selected for its innovative recombinant protein, which has the potential to accelerate ...
Advance Biotech Grant
hemorrhagic stroke
ischemic stroke
+2